# Higin Capital

> Higin Capital is a VC fund in Kumamoto backing Medical and Biotechnology. See 27 investments, check sizes, portfolio and contact details. Updated Aug 2026.

- Type: VC Fund
- Location: Kumamoto, Japan
- Total investments: 27
- Last investment: Jun 2026
- Lead investor: 4%
- Fund size: $137M
- Last fund: Mar 2020
- Last updated: Aug 2026
- Website: https://higincapital.co.jp/

Higin Capital is a VC fund in Kumamoto focused on Medical and Biotechnology. Higegin Capital is a venture capital firm.

## Contacts

5 contacts available for Higin Capital. Shizune tracks 1 team members at Higin Capital. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-team-emails/higegin-capital?utm_source=investor_profile

## Round sizes

| Stage | Round size |
| --- | --- |
| Seed | $633k–$5.4M |
| Series A | $1.2M–$9.1M |
| Series B | $3.8M–$17M |

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Medical | 5 | 19% |
| Biotechnology | 5 | 19% |
| Software | 4 | 15% |
| Medical Device | 4 | 15% |
| Information Technology | 4 | 15% |

46 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series A | 6 | 22% |
| Series B | 6 | 22% |
| Venture - Series Unknown | 5 | 19% |
| Seed | 4 | 15% |
| Funding Round | 3 | 11% |

6 stages tracked in total.

## Team

| Name | Title | Investments | Profile |
| --- | --- | --- | --- |
| Akifumi Matsuo | Group Manager | 1 | https://shizune.co/investors/profile/akifumi-matsuo |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| EUV Photon | EUV Photon is an irradiation services company that conducts processing, evaluation, and measurement of materials for EUV lights. | $5.4M | Seed | Jun 29, 2026 |  |
| Molmir | Molmir is a biotech company that conducts research and develops treatments for intractable diseases based on sensing technology. | $1.9M | Series A | Apr 22, 2026 |  |
| Restore Vision | Restore Vision is a biotechnology company developing a visual restoration gene therapy for retinitis pigmentosa. Restore Vision develops eye disease therapeutic agents. | $8.2M | Series B | Apr 15, 2026 |  |
| Photo Electron Soul | Photo electron Soul mission is to innovate the world of "seeing (fine observation)" and "creating (fine processing)" through the development of photocathode electron beam technology.　The photocathode electron beam technology developed by our company will produce next generation electron beams with high performance andversatility (pulse structure, low dispersion, large current). By renewing the electron beam, which is a key device for industrial equipment such as electron microscopes, semiconductor device manufacturing / inspection equipment, and metal 3D printers, it is possible to realize fine observation, fine processing, high throughput, etc. Breakthroughs in a wide range of fields such as science, materials, and electronics. | $5.7M | Venture - Series Unknown | Mar 31, 2026 |  |
| Bluefield Energy | Bluefield Energy redefines Japan's electricity sector through technology-driven renewable energy solutions. Its mission centers on liberating people and society from energy constraints by tackling high costs, environmental impact, and supply instability. | $3.9M | Seed | Feb 25, 2026 |  |
| Surv Biopharma | Surv Biopharma develops a drug discovery platform that facilitates research and development of veterinary drugs and pharmaceutical products. | $14.1M | Series B | Nov 11, 2025 |  |
| KAICO | KAICO is a pharmaceuticals, diagnostic drugs production company. | $3.8M | Series B | Apr 15, 2025 |  |
| AMI | AMI Corp is engaged in medical consulting, medical device development and writing. |  | Series C | Dec 12, 2024 |  |
| F.MED | F.MED is a manufacturing company that designs and develops robotic microsurgical devices for the healthcare industry. | $2.7M | Series A | Jul 08, 2024 |  |
| Salmontech | Salmontech is a medical device company specialising in the development of ultrasound diagnostic equipment, along with related peripherals and software. Its flagship product is the wearable biosensing ultrasound probe known as "SalmonEcho." The company is dedicated to advancing medical ultrasound technology and its associated devices andsoftware. | $633.5K | Seed | Jun 18, 2024 |  |

10 of 27 investments shown.

## Co-investors
- [Mitsubishi UFJ Capital](https://shizune.co/investors/profile/mitsubishi-ufj-capital) — VC Fund, 7 deals together
- [Sagin Capital & Consulting](https://shizune.co/investors/profile/sagin-capital-consulting) — VC Fund, 5 deals together
- [Agribusiness Investment Development](https://shizune.co/investors/profile/agribusiness-investment-consultation) — VC Fund, 4 deals together
- [UntroD Capital](https://shizune.co/investors/profile/real-tech-holdings) — VC Fund, 4 deals together
- [SMBC Venture Capital](https://shizune.co/investors/profile/smbc-venture-capital) — VC Fund, 4 deals together
- [FFG Venture Business Partners](https://shizune.co/investors/profile/ffg-venture-business-partners) — VC Fund, 3 deals together

## Similar investors

### Similar industry
- [SOSV](https://shizune.co/investors/profile/sosv) — VC Fund
- [ARCH Venture Partners](https://shizune.co/investors/profile/arch-venture-partners) — VC Fund
- [OrbiMed](https://shizune.co/investors/profile/orbimed-advisors) — VC Fund

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund

### Similar country
- [Mitsubishi UFJ Capital](https://shizune.co/investors/profile/mitsubishi-ufj-capital) — VC Fund
- [SMBC Venture Capital](https://shizune.co/investors/profile/smbc-venture-capital) — VC Fund
- [Mizuho Capital](https://shizune.co/investors/profile/mizuho-capital) — VC Fund

## Featured in investor lists
- [Health Care VC Funds in Japan](https://shizune.co/investors/health-care-vc-funds-japan)
- [Health Care Investors in Japan](https://shizune.co/investors/health-care-investors-japan)
- [Medical Investors in Japan](https://shizune.co/investors/medical-investors-japan)
- [Biotechnology Investors in Japan](https://shizune.co/investors/biotechnology-investors-japan)
- [Biotechnology VC Funds in Japan](https://shizune.co/investors/biotechnology-vc-funds-japan)
- [Biotech VC Funds in Japan](https://shizune.co/investors/biotech-vc-funds-japan)

## FAQ

### What does Higin Capital invest in?

Higin Capital invests primarily in Medical, Biotechnology and Software startups, most often at Series A and Series B stage. Most of the 27 investments tracked by Shizune back companies in Japan. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### What is Higin Capital's check size?

Higin Capital typically joins rounds of $633k–$5.4M at Seed, $1.2M–$9.1M at Series A and $3.8M–$17M at Series B. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Higin Capital participates in.

### How do I contact Higin Capital?

Public channels for Higin Capital include the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### Who are the partners at Higin Capital?

The team at Higin Capital includes Akifumi Matsuo (Group Manager). The Team section lists each member with their title, investment count and links.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co